Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

661 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review.
Wallis RS, Zumla A. Wallis RS, et al. Among authors: zumla a. Open Forum Infect Dis. 2016 Sep 7;3(3):ofw151. doi: 10.1093/ofid/ofw151. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27800526 Free PMC article. Review.
Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis.
Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A. Johnson JL, et al. Among authors: zumla a. Int J Tuberc Lung Dis. 2004 Nov;8(11):1348-54. Int J Tuberc Lung Dis. 2004. PMID: 15581204 Clinical Trial.
Lung remodeling in pulmonary tuberculosis.
Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Dheda K, et al. Among authors: zumla a. J Infect Dis. 2005 Oct 1;192(7):1201-9. doi: 10.1086/444545. Epub 2005 Aug 29. J Infect Dis. 2005. PMID: 16136463 Review.
The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.
Lala S, Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Rook GA, Keshav S, Zumla A. Lala S, et al. Among authors: zumla a. BMC Infect Dis. 2007 Aug 16;7:96. doi: 10.1186/1471-2334-7-96. BMC Infect Dis. 2007. PMID: 17705850 Free PMC article.
Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
Rook GA, Hernández-Pando R, Zumla A. Rook GA, et al. Among authors: zumla a. J Infect Dis. 2009 Mar 1;199(5):613-8. doi: 10.1086/596654. J Infect Dis. 2009. PMID: 19199549
Biomarkers for tuberculosis disease activity, cure, and relapse.
Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. Wallis RS, et al. Among authors: zumla a. Lancet Infect Dis. 2009 Mar;9(3):162-72. doi: 10.1016/S1473-3099(09)70042-8. Lancet Infect Dis. 2009. PMID: 19246020 Review.
Operational research and MDG tuberculosis control targets.
Zumla A, Cobelens F. Zumla A, et al. Lancet Infect Dis. 2012 Apr;12(4):262-3. doi: 10.1016/S1473-3099(12)70034-8. Epub 2012 Mar 7. Lancet Infect Dis. 2012. PMID: 22402009 No abstract available.
Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.
Zumla A, Maeurer M. Zumla A, et al. J Infect Dis. 2012 May 15;205 Suppl 2:S335-9. doi: 10.1093/infdis/jir881. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448017
Innovative trial designs are practical solutions for improving the treatment of tuberculosis.
Phillips PP, Gillespie SH, Boeree M, Heinrich N, Aarnoutse R, McHugh T, Pletschette M, Lienhardt C, Hafner R, Mgone C, Zumla A, Nunn AJ, Hoelscher M. Phillips PP, et al. Among authors: zumla a. J Infect Dis. 2012 May 15;205 Suppl 2:S250-7. doi: 10.1093/infdis/jis041. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448027
Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
Bates M, O'Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Bates M, et al. Among authors: zumla a. Lancet Infect Dis. 2013 Jan;13(1):36-42. doi: 10.1016/S1473-3099(12)70245-1. Epub 2012 Nov 5. Lancet Infect Dis. 2013. PMID: 23134697
661 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page